PURPOSE: The aim of this study was to investigate the relationships between latent viral shedding of Epstein-Barr virus (EBV) in saliva, upper-respiratory illness, and mucosal immune suppression in a cohort of highly trained swimmers undertaking intensive training. METHODS: Saliva was collected before selected training sessions from 14 elite male swimmers during a 30-d period of intensive training. Prior infection with EBV was determined by EBV antibody serology. Salivary IgA concentrations were measured by enzyme linked immunosorbent assay (ELISA), and EBV viral shedding (EBV-DNA) was detected by polymerase chain reaction (PCR). Symptoms of upper-respiratory illness were recorded daily. RESULTS: Eleven swimmers (79%) were seropositive for prior EBV infection. Seven EBV seropositive swimmers (64%) had EBV-DNA detected during the study period. Upper-respiratory symptoms (URS) were reported in six of seven swimmers in whom EBV-DNA was detected and in three of four swimmers with no EBV-DNA detection. No URS were reported in the EBV seronegative swimmers. There was a statistically significant relationship between EBV serology status and URS (P = 0.027). EBV-DNA was detected in saliva before the appearance of URS. Salivary IgA levels were significantly lower immediately before the URS (P = 0.01) compared with subsequent peak IgA levels and declined to pre-URS levels on average 11 d after the first appearance of URS. CONCLUSIONS: The time course of appearance of EBV-DNA in relation to URS suggests latent viral EBV shedding may be a contributing factor in the URS. The low levels of salivary IgA detected before the URS indicated transient mucosal immune suppression in the study cohort. The viral shedding may alternatively be a reflection of the altered immune control mechanisms that occur in response to intensive exercise and unrelated to the URS.
PURPOSE: The aim of this study was to investigate the relationships between latent viral shedding of Epstein-Barr virus (EBV) in saliva, upper-respiratory illness, and mucosal immune suppression in a cohort of highly trained swimmers undertaking intensive training. METHODS: Saliva was collected before selected training sessions from 14 elite male swimmers during a 30-d period of intensive training. Prior infection with EBV was determined by EBV antibody serology. Salivary IgA concentrations were measured by enzyme linked immunosorbent assay (ELISA), and EBV viral shedding (EBV-DNA) was detected by polymerase chain reaction (PCR). Symptoms of upper-respiratory illness were recorded daily. RESULTS: Eleven swimmers (79%) were seropositive for prior EBV infection. Seven EBV seropositive swimmers (64%) had EBV-DNA detected during the study period. Upper-respiratory symptoms (URS) were reported in six of seven swimmers in whom EBV-DNA was detected and in three of four swimmers with no EBV-DNA detection. No URS were reported in the EBV seronegative swimmers. There was a statistically significant relationship between EBV serology status and URS (P = 0.027). EBV-DNA was detected in saliva before the appearance of URS. Salivary IgA levels were significantly lower immediately before the URS (P = 0.01) compared with subsequent peak IgA levels and declined to pre-URS levels on average 11 d after the first appearance of URS. CONCLUSIONS: The time course of appearance of EBV-DNA in relation to URS suggests latent viral EBV shedding may be a contributing factor in the URS. The low levels of salivary IgA detected before the URS indicated transient mucosal immune suppression in the study cohort. The viral shedding may alternatively be a reflection of the altered immune control mechanisms that occur in response to intensive exercise and unrelated to the URS.
Authors: Philippe Hellard; Fanny Guimaraes; Marta Avalos; Nicolas Houel; Christophe Hausswirth; Jean François Toussaint Journal: Med Sci Sports Exerc Date: 2011-06 Impact factor: 5.411
Authors: E Tiollier; D Gomez-Merino; P Burnat; J-C Jouanin; C Bourrilhon; E Filaire; C Y Guezennec; M Chennaoui Journal: Eur J Appl Physiol Date: 2004-10-14 Impact factor: 3.078
Authors: R L Clancy; M Gleeson; A Cox; R Callister; M Dorrington; C D'Este; G Pang; D Pyne; P Fricker; A Henriksson Journal: Br J Sports Med Date: 2006-04 Impact factor: 13.800
Authors: Emily C P LaVoy; David C Nieman; Dru A Henson; R Andrew Shanely; Amy M Knab; Lynn Cialdella-Kam; Richard J Simpson Journal: Eur J Appl Physiol Date: 2013-08-09 Impact factor: 3.078
Authors: Kathleen B Schwarz; Dominic Dell Olio; Steven J Lobritto; M James Lopez; Norberto Rodriguez-Baez; Nada A Yazigi; Steven H Belle; Song Zhang; Robert H Squires Journal: J Pediatr Gastroenterol Nutr Date: 2014-11 Impact factor: 2.839
Authors: Naama W Constantini; Gal Dubnov-Raz; Ben-Bassat Eyal; Elliot M Berry; Avner H Cohen; Harri Hemilä Journal: Eur J Pediatr Date: 2010-08-06 Impact factor: 3.183